FDA inspection
Aurisco Pharmaceutical Co., Ltd: FDA inspection ending Dec 13, 2019
FDA inspection 1116051 · Voluntary Action Indicated (VAI) · Tiantai
Key facts
| Inspection ID | 1116051 |
|---|---|
| Firm | Aurisco Pharmaceutical Co., Ltd |
| FEI number | 3005793293 |
| Address | Badu Industrial Park, Zone |
| City | Tiantai |
| Fiscal year | 2020 |
| Inspection end date | Dec 13, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data